Polycystic Ovarian Syndrome (PCOS) Treatment Market is Expected to Reach USD 8735.97 million by 2029

PRESS RELEASE
Published September 26, 2023

Polycystic Ovarian Syndrome (PCOS) Treatment Market research report offers an array of insights about HEALTHCARE industry and business solutions that will support to stay ahead of the competition. The collected information is checked and verified by market experts before presenting it to the end user. The report provides company profiling of key players in the HEALTHCARE industry, carefully analyzing their core competencies, and drawing a competitive landscape for the market. All this data and statistics covered in the first class report lead to actionable ideas, improved decision-making and better mapping business strategies. Businesses can rely upon the top-notch Polycystic Ovarian Syndrome (PCOS) Treatment Market report to accomplish an utter success.

The global polycystic ovarian syndrome (PCOS) treatment market is witnessing substantial growth due to the increasing prevalence of PCOS worldwide. PCOS is a common hormonal disorder affecting women of reproductive age, leading to various health issues. The market is driven by the growing awareness about PCOS and its related complications, advancements in medical technologies, and the development of novel treatment options. Pharmaceuticals and lifestyle interventions are prominent treatment approaches, aiming to manage PCOS symptoms and improve the quality of life for affected individuals globally.

The increased prevalence of polycystic ovarian syndrome will help the polycystic ovarian syndrome (PCOS) treatment market to grow dramatically as the increased cases of polycystic ovarian syndrome, will increase the demand for the effective treatment procedure and medications, thus benefitting the market positively. According to the Centers for Disease Control and Prevention, approximately 5 million women of reproductive age have polycystic ovarian syndrome. The surge in cases will therefore directly offer opportunities for market to grow lucratively over forecast period.

Request a Sample PDF:  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-polycystic-ovarian-syndrome-pcos-treatment-market&Shri

Global Polycystic ovarian syndrome (PCOS) treatment Market was valued at USD 5481.0 million in 2021 and is expected to reach USD 8735.97 million by 2029, registering a CAGR of 6.0% during the forecast period of 2022-2029. The “laparoscopic ovarian drilling” accounts for the largest surgery segment in the polycystic ovarian syndrome (PCOS) treatment market within the forecasted period as they are the most common surgeries performed by doctors in critical conditions. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Overview:

The polycystic ovarian syndrome (PCOS), is a hormonal condition that affects many women of childbearing age. Polycystic Ovary Syndrome (PCOS) is characterized by irregular or extended menstrual cycles and elevated amounts of male hormones. Although there is currently no cure for PCOS, numerous drugs are used to regulate the menstrual cycle and manage the symptoms of the condition.  It is also caused due to high levels of androgens, low-grade inflammation, cysts in the ovaries, excess insulin and genetic disorders.

Drivers

  • Growing Burden Of Polycystic Ovarian Syndrome (PCOS)

The surging cases of polycystic ovarian syndrome (PCOS), across the world is the most significant factor driving the growth for this market. Additionally, the other factors, including rising prevalence of diabetes and obesity among women, increasing hormonal disorders in women, socioeconomic factors, change in sedentary lifestyle, and growing consumption of unhealthy diet, are also expected to accelerate the market’s overall growth.

Furthermore, the expanding healthcare sector, adoption of combination drugs, and rising patient adoption are also expected to fuel market growth. Moreover, the rising awareness among the patients and doctors regarding the chronic diseases and hospital-acquired infections also cushions the market’s growth within the forecasted period. The focus of leading manufacturers on expanding their geographic presence is also projected to bolster the market’s growth.

Opportunities

  • Growing Investments and Advancements

Moreover, the technological advancements for detection of polycystic ovary syndrome and the growth in awareness about polycystic ovarian syndrome treatment are estimated to generate lucrative opportunities for the market. The untapped potential offered by developing economies combined with rise in adoption of polycystic ovarian syndrome treatment products will further offer numerous growth opportunities for the market.

Browse Complete Report Details- https://www.databridgemarketresearch.com/reports/global-polycystic-ovarian-syndrome-pcos-treatment-market?Shri

Some of the major players operating in the polycystic ovarian syndrome (PCOS) treatment market are

  • Bayer AG (Germany)
  • Allergan (Ireland)
  • Merck & Co (U.S.)
  • Pfizer Inc (U.S.)
  • Amgen (U.S.)
  • Agile Therapeutics (U.S.)
  • Ferring B.V. (U.S.)
  • Addex Therapeutics (Switzerland)
  • Mylan N.V. (U.S.)
  • Lupin (India)
  • Blairex Laboratories Inc (U.S.)
  • Apothecus Pharmaceutical Corp (U.S.)
  • Eli Lilly And Company (U.S.)
  • Novartis AG (Switzerland)
  • BIOCAD Global (Russia)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Johnson & Johnson Services, Inc (U.S.)

Recent Developments

  • In January 2020, Abbvie had a clinical trial in the works with the chemical Elagolix, which is being tested for safety and efficacy in women with polycystic ovary syndrome. The business is now conducting a Phase 2 multicenter, double-blind, randomised, placebo-controlled research to evaluate Elagolix’s safety and efficacy in women with polycystic ovarian syndrome (PCOS).
  • In Jan 2020, Evotec SE and Bayer AG launched a new five-year multi-target collaboration with Celmatix Inc. to develop various clinical candidates for the treatment of polycystic ovarian syndrome, which is projected to drive the market during the forecast period.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the this market
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies

Critical Insights Related to This Market Included in the Report:

  • Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market
  • Value chain analysis of prominent players in the market
  • Current trends influencing the dynamics of this market across various geographies
  • Recent mergers, acquisitions, collaborations, and partnerships
  • Revenue growth of this industry over the forecast period
  • Marketing strategy study and growth trends
  • Growth driven factor analysis
  • Emerging recess segments and region-wise market
  • An empirical evaluation of the curve of this market
  • Ancient, Present, and Probable scope of the market from both prospect value and volume

Polycystic Ovarian Syndrome (PCOS) Treatment Market Scope

Drugs

  • Oral Contraceptives
  • Antiandrogen
  • Insulin-Sensitizing Agents
  • Antidepressants
  • Anti-Obesity

On the basis of drugs, the polycystic ovarian syndrome (PCOS) treatment market is segmented into oral contraceptives, antiandrogen, insulin-sensitizing agents, antidepressants and anti-obesity.

Surgery

  • Wedge Resection
  • Laparoscopic Drilling

On the basis of surgery, the polycystic ovarian syndrome (PCOS) treatment market is segmented into wedge resection and laparoscopic drilling. Laparoscopic ovarian drilling is expected to register a major share in the market as they are the most common surgeries performed by doctors in critical conditions.

End User

  • Hospital
  • Ambulatory Surgical Centers
  • Others

On the basis of end user, the polycystic ovarian syndrome (PCOS) treatment market is bifurcated into hospital, ambulatory surgical centers and others.

Browse Detailed Summary of Research Report with TOC:  https://www.databridgemarketresearch.com/toc/?dbmr=global-polycystic-ovarian-syndrome-pcos-treatment-market&Shri

Top DBMR Healthcare Reports:        

Global Bipolar Disorder Treatment Market – Industry Trends and Forecast to 2029

Global Diabetic Macular Edema Treatment Market – Industry Trends and Forecast to 2029

Global 3D Cone Beam Computed Tomography (CBCT) Systems Market – Industry Trends and Forecast to 2029

Global Pregnancy Care Products Market – Industry Trends and Forecast to 2029

Global Hair and Care Market – Industry Trends and Forecast to 2030

Global Vascular Stent Market – Industry Trends and Forecast to 2029

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

CDN Newswire